American Cannabis Company, Inc.

OTCPK:AMMJ Stock Report

Market Cap: US$74.3k

American Cannabis Company Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Ellis Smith

Chief executive officer

US$350.0k

Total compensation

CEO salary percentage42.9%
CEO tenure11.8yrs
CEO ownership12.2%
Management average tenureno data
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Ellis Smith's remuneration changed compared to American Cannabis Company's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-US$3m

Dec 31 2023US$350kUS$150k

-US$4m

Sep 30 2023n/an/a

-US$121k

Jun 30 2023n/an/a

-US$391k

Mar 31 2023n/an/a

-US$574k

Dec 31 2022US$142kUS$130k

-US$633k

Sep 30 2022n/an/a

-US$2m

Jun 30 2022n/an/a

-US$2m

Mar 31 2022n/an/a

-US$2m

Dec 31 2021US$99kUS$90k

-US$1m

Sep 30 2021n/an/a

-US$767k

Jun 30 2021n/an/a

-US$744k

Mar 31 2021n/an/a

-US$477k

Dec 31 2020US$94kUS$85k

-US$532k

Sep 30 2020n/an/a

-US$741k

Jun 30 2020n/an/a

-US$560k

Mar 31 2020n/an/a

-US$285k

Dec 31 2019US$110kUS$88k

-US$302k

Sep 30 2019n/an/a

-US$347k

Jun 30 2019n/an/a

-US$596k

Mar 31 2019n/an/a

-US$974k

Dec 31 2018US$88kUS$88k

-US$951k

Compensation vs Market: Ellis's total compensation ($USD350.00K) is below average for companies of similar size in the US market ($USD649.07K).

Compensation vs Earnings: Ellis's compensation has increased whilst the company is unprofitable.


CEO

Ellis Smith (47 yo)

11.8yrs

Tenure

US$350,000

Compensation

Mr. Ellis Lamar Smith serves as Chief Executive Officer & Chief Financial Officer of American Cannabis Company, Inc. since December 31, 2021 and serves as its Director and serves as its Chairman. He had be...


Board Members

NamePositionTenureCompensationOwnership
Ellis Smith
Co-Founder10.3yrsUS$350.00k12.2%
$ 9.1k
Peggy Moore
Member of Advisory Board3.8yrsno datano data
Karen Thomas
Member of Advisory Board3.8yrsno datano data
Christine Comatos
Member of Advisory Board3.8yrsno datano data
Elvin Moon
Member of Advisory Board3.8yrsno datano data
Breck Speed
Member of Advisory Board3.8yrsno datano data
Greg Shoenfeld
Member of Advisory Board3.8yrsno datano data
Carolyn Burek
Member of Advisory Board3.8yrsno datano data

3.8yrs

Average Tenure

Experienced Board: AMMJ's board of directors are considered experienced (3.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/03 08:05
End of Day Share Price 2025/01/03 00:00
Earnings2024/03/31
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

American Cannabis Company, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution